Clene (CLNN)
(Delayed Data from NSDQ)
$6.11 USD
-0.24 (-3.78%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $6.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Clene Inc. (CLNN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$48.33 | $100.00 | $20.00 | 661.10% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Clene Inc. comes to $48.33. The forecasts range from a low of $20.00 to a high of $100.00. The average price target represents an increase of 661.1% from the last closing price of $6.35.
Analyst Price Targets (6 )
Broker Rating
Clene Inc. currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by six brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on six recommendations.
Of the six recommendations deriving the current ABR, six are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 6 | 6 | 6 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/11/2024 | The Benchmark Company | Bruce D Jackson | Strong Buy | Strong Buy |
9/16/2024 | H.C. Wainwright & Co. | Joseph Pantginis | Strong Buy | Strong Buy |
9/10/2024 | EF Hutton Financial | Jason Kolbert | Not Available | Strong Buy |
8/7/2024 | Roth Capital Partners | Jonathan Aschoff | Strong Buy | Strong Buy |
8/6/2024 | Canaccord Genuity | Sumant Kulkarni | Strong Buy | Strong Buy |
7/12/2024 | Maxim Group | Naz Rahman | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 6 |
Average Target Price | $48.33 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 89 of 252 |
Current Quarter EPS Est: | -1.34 |
CLNN FAQs
Clene Inc. (CLNN) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 6 brokerage firms.
The average price target for Clene Inc. (CLNN) is $48.33. The current on short-term price targets is based on 2 reports.
The forecasts for Clene Inc. (CLNN) range from a low of $20 to a high of $100. The average price target represents a increase of $691.00 from the last closing price of $6.11.
The current UPSIDE for Clene Inc. (CLNN) is 691.00%
Based on short-term price targets offered by six analysts, the average price target for Clene Inc. comes to $48.33. The forecasts range from a low of $20.00 to a high of $100.00. The average price target represents an increase of 661.1% from the last closing price of $6.35.